首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design and synthesis of a second series of triazole-based compounds as potent dual mPGES-1 and 5-lipoxygenase inhibitors
【24h】

Design and synthesis of a second series of triazole-based compounds as potent dual mPGES-1 and 5-lipoxygenase inhibitors

机译:设计和合成基于三唑的第二系列化合物,作为有效的双重mPGES-1和5-脂氧合酶抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

Microsomal prostaglandin E 2 synthase (mPGES)-1 and 5-lipoxygenase (5-LO) are pivotal enzymes in the biosynthesis of the pro-inflammatory PGE 2 and leukotrienes, respectively. The design and synthesis of a second series of mPGES-1 inhibitors based on a triazole scaffold are described. Our studies allowed us to draw a tentative SAR profile and to optimize this series with the identification of compounds 10, 11 and 14-15 which displayed potent mPGES-1 inhibition in a cell-free assay. In addition, compounds 5, 10, 12 and 14-16 also blocked 5-LO activity in cell-free and cell-based test systems, emerging as very promising candidates for the development of safer and more effective anti-inflammatory drugs.
机译:微粒体前列腺素E 2合酶(mPGES)-1和5-脂氧合酶(5-LO)分别是促炎性PGE 2和白三烯生物合成中的关键酶。描述了基于三唑支架的第二系列mPGES-1抑制剂的设计和合成。我们的研究使我们能够绘制暂定的SAR谱图,并通过鉴定在无细胞试验中显示出有效mPGES-1抑制作用的化合物10、11和14-15来优化该系列。此外,化合物5、10、12和14-16在无细胞和基于细胞的测试系统中也阻断了5-LO活性,成为开发更安全,更有效的抗炎药的极有希望的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号